Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Medical Decision Making
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Badia, X.
Right arrow Articles by Kind, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Badia, X.
Right arrow Articles by Kind, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

A Comparison of United Kingdom and Spanish General Population Time Trade-off Values for EQ-5D Health States

Xavier Badia, PhD

Catalan Institute of Public Health, Barcelona, Spain

Montserrat Roset, BSc

Catalan Institute of Public Health, Barcelona, Spain

Michael Herdman, MSc

Catalan Institute of Public Health, Barcelona, Spain

Paul Kind, PhD

Catalan Institute of Public Health, Barcelona, Spain

Few studies have compared preference values for health states obtained in different countries. The present study compared Spanish and United Kingdom (UK) time trade-off values for EuroQol-5D health states. The same preference elicitation protocol was followed in both countries. Differences in values for 43 health states rated directly were analyzed using t tests, and regression coefficients generated by random effects modeling were compared by aggregating the 2 value sets and using dummy variables to analyze country effect by dimension and level of severity. For the milder health states, Spanish and UK value assignation was similar; for intermediate health states, Spanish values were both higher and lower than UK values, whereas for health states worse than death, UK values were generally higher than Spanish values. There were statistically significant differences (P < 0.01) in values for 34.9% of health states rated directly, and some preference reversals between countries. UK raters ascribed greater importance to dimensions of pain/discomfort and anxiety/depression, whereas Spanish raters placed more importance on functional dimensions of mobility and self-care. Further analysis is required to determine how these differences affect cost-effectiveness and cost-utility analyses.

Key Words: EQ-5D • health states • preference values • United Kingdom • Spain • comparison

Medical Decision Making, Vol. 21, No. 1, 7-16 (2001)
DOI: 10.1177/0272989X0102100102


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Scand J Public HealthHome page
K. U. Wittrup-Jensen, J. Lauridsen, C. Gudex, and K. M. Pedersen
Generation of a Danish TTO value set for EQ-5D health states
Scand J Public Health, July 1, 2009; 37(5): 459 - 466.
[Abstract] [PDF]


Home page
J Bone Joint Surg BrHome page
M. Zlowodzki, O. Brink, J. Switzer, S. Wingerter, J. Woodall Jr, B. A. Petrisor, P. J. Kregor, D. R. Bruinsma, and M. Bhandari
The effect of shortening and varus collapse of the femoral neck on function after fixation of intracapsular fracture of the hip: A MULTI-CENTRE COHORT STUDY
J Bone Joint Surg Br, November 1, 2008; 90-B(11): 1487 - 1494.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
I. Olivieri, S. de Portu, C. Salvarani, A. Cauli, E. Lubrano, A. Spadaro, F. Cantini, M. S. Cutro, A. Mathieu, M. Matucci-Cerinic, et al.
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy
Rheumatology, November 1, 2008; 47(11): 1664 - 1670.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
Nan Luo, J. A. Johnson, J. W. Shaw, and S. J. Coons
A Comparison of EQ-5D Index Scores Derived from the US and UK Population-Based Scoring Functions
Med Decis Making, May 1, 2007; 27(3): 321 - 326.
[Abstract] [PDF]


Home page
Med Decis MakingHome page
R. Lilford, A. Girling, D. Braunholtz, W. Gillett, J. Gordon, C. A. Brown, and A. Stevens
Cost-Utility Analysis When Not Everyone Wants the Treatment: Modeling Split-Choice Bias
Med Decis Making, January 1, 2007; 27(1): 21 - 26.
[Abstract] [PDF]


Home page
Med Decis MakingHome page
N. Luo, Q. Wang, D. Feeny, G. Chen, S.-C. Li, and J. Thumboo
Measuring Health Preferences for Health Utilities Index Mark 3 Health States: A Study of Feasibility and Preference Differences among Ethnic Groups in Singapore
Med Decis Making, January 1, 2007; 27(1): 61 - 70.
[Abstract] [PDF]


Home page
Med Decis MakingHome page
L. M. Lamers, P. F. M. Stalmeier, P. F. M. Krabbe, and J. J. V. Busschbach
Inconsistencies in TTO and VAS Values for EQ-5D Health States
Med Decis Making, March 1, 2006; 26(2): 173 - 181.
[Abstract] [PDF]


Home page
Eur Heart JHome page
M. J. Calvert, N. Freemantle, G. Yao, J. G.F. Cleland, L. Billingham, J.-C. Daubert, S. Bryan, and on behalf of the CARE-HF Investigators
Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial
Eur. Heart J., December 2, 2005; 26(24): 2681 - 2688.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Gringeri, L. G. Mantovani, L. Scalone, and P. M. Mannucci
Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group
Blood, October 1, 2003; 102(7): 2358 - 2363.
[Abstract] [Full Text] [PDF]